T. Depaulis et al., 2-METHOXY-N-(1-AZABICYCLO[2.2.2]OCT-3-YL)BENZAMIDE (TRIZAC), A HIGH-AFFINITY LIGAND FOR THE 5-HT-3 RECEPTOR, Bioorganic & medicinal chemistry letters, 6(22), 1996, pp. 2657-2662
TRIZAC is one of the most potent 5-HT-3 receptor antagonist reported t
o date, having 20-fold higher affinity than (S)-5-iodozacopride. This
high affinity (K-i 0.05 +/- 0.01 nM) and a moderate apparent Lipophili
city (log P-app 2.12) makes TRIZAC a promising ligand for studying 5-H
T-3 receptors. Copyright (C) 1996 Elsevier Science Ltd